Eton Pharmaceuticals, Inc. SEC filings ETON

Eton Pharmaceuticals, Inc. has 421 filings in SEC EDGAR's recent list, going back to Jun 28, 2017. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Eton Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Nov 2, 2026 Nov 2, 2026
8-K Current report
Material agreement, Acquisition or sale of assets
Oct 14, 2026 Oct 14, 2026
4 Insider transaction Oct 6, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 6, 2026 —
8-K Current report
Other events
Sep 28, 2026 Sep 28, 2026
4/A Form 4/a Aug 31, 2026 Aug 28, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
144 Notice of proposed sale Aug 28, 2026 —
4 Insider transaction Aug 24, 2026 Aug 24, 2026
144 Notice of proposed sale Aug 24, 2026 —
4 Insider transaction Aug 20, 2026 Aug 19, 2026
144/A Filing Aug 20, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
3 Initial insider ownership Aug 12, 2026 Jul 31, 2026
8-K Current report
Material agreement, Acquisition or sale of assets
Aug 5, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
8-K Current report
Officer or director change
Aug 4, 2026 Jul 31, 2026
8-K Current report
Other events
Jul 29, 2026 Jul 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
4/A Filing Jul 17, 2026 Jul 14, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jul 14, 2026 Jul 12, 2026
4 Insider transaction Jul 13, 2026 Jul 12, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
4 Insider transaction Jun 17, 2026 Jun 17, 2026
144 Notice of proposed sale Jun 17, 2026 —
8-K Current report
Shareholder vote results
Jun 9, 2026 Jun 9, 2026
144 Notice of proposed sale Jun 2, 2026 —
3 Initial insider ownership Jun 1, 2026 Jun 1, 2026
4 Insider transaction May 29, 2026 May 28, 2026
144 Notice of proposed sale May 28, 2026 —
4 Insider transaction May 27, 2026 May 22, 2026
144 Notice of proposed sale May 22, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets
May 19, 2026 May 18, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
8-K Current report
Other events
May 1, 2026 May 1, 2026
8-K Current report
Other events
Apr 27, 2026 Apr 27, 2026
DEF 14A Proxy statement Apr 24, 2026 Jun 9, 2026
4 Insider transaction Apr 22, 2026 Apr 21, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 16, 2026 Apr 16, 2026
8-K Current report
Material agreement, New debt
Apr 15, 2026 Apr 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
S-8 Employee stock plan registration Mar 6, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets
Mar 2, 2026 Feb 27, 2026
8-K Current report
Other events
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
8-K Current report
Other events
Feb 2, 2026 Feb 2, 2026
UPLOAD Letter from the SEC Jan 27, 2026 —
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 14, 2026 —
144 Notice of proposed sale Jan 14, 2026 —
CORRESP Letter to the SEC Jan 14, 2026 —
144 Notice of proposed sale Jan 14, 2026 —
UPLOAD Letter from the SEC Dec 19, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
8-K Current report
Regulation FD disclosure
Dec 4, 2025 Dec 4, 2025
S-8 Employee stock plan registration Nov 19, 2025 —
8-K/A Amended current report
Acquisition or sale of assets
Nov 18, 2025 Dec 19, 2024
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2025 —
4 Insider transaction Aug 20, 2025 Aug 19, 2025
144 Notice of proposed sale Aug 19, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
8-K Current report
Other events
Jul 8, 2025 Jul 8, 2025
8-K Current report
Other events
Jun 27, 2025 Jun 27, 2025
8-K Current report
Auditor change
Jun 20, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
144 Notice of proposed sale Jun 12, 2025 —
8-K Current report
Shareholder vote results
Jun 10, 2025 Jun 10, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
144 Notice of proposed sale Jun 3, 2025 —
8-K Current report
Other events
May 28, 2025 May 28, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K/A Amended current report
Acquisition or sale of assets, Other events
May 2, 2025 Dec 19, 2024
8-K Current report
Other events
Apr 28, 2025 Apr 28, 2025
DEF 14A Proxy statement Apr 25, 2025 Jun 10, 2025
8-K Current report
Other events
Apr 1, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
Mar 18, 2025 Mar 18, 2025
8-K Current report
Results of operations
Mar 18, 2025 Mar 18, 2025
10-K Annual report Mar 18, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 14, 2025 Mar 14, 2025
8-K/A Amended current report
Acquisition or sale of assets, Other events
Mar 7, 2025 Dec 19, 2024
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Other events
Feb 7, 2025 Feb 7, 2025
8-K Current report
Other events
Feb 6, 2025 Feb 6, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
8-K Current report
Acquisition or sale of assets
Jan 3, 2025 Dec 31, 2024
8-K Current report
Acquisition or sale of assets
Dec 20, 2024 Dec 19, 2024
8-K Current report
Other events
Dec 17, 2024 Dec 17, 2024
8-K Current report
Material agreement
Dec 12, 2024 Dec 10, 2024
424B5 Prospectus supplement Dec 12, 2024 —
3 Initial insider ownership Dec 9, 2024 Dec 2, 2024
SC 13G Ownership over 5% (passive) Dec 9, 2024 —
8-K Current report
Other events
Dec 3, 2024 Dec 3, 2024
8-K Current report
Material agreement
Nov 25, 2024 Nov 22, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Other events
Nov 7, 2024 Nov 5, 2024
4 Insider transaction Oct 25, 2024 Oct 23, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
8-K Current report
Material agreement
Oct 3, 2024 Oct 2, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
SC 13G/A Amended ownership over 5% (passive) Sep 12, 2024 —
3 Initial insider ownership Sep 12, 2024 Sep 9, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K/A Amended current report
Shareholder vote results
Aug 2, 2024 Jun 11, 2024
8-K Current report
Other events
Jul 15, 2024 Jul 15, 2024
8-K Current report
Auditor change
Jun 21, 2024 Jun 14, 2024
8-K Current report
Shareholder vote results
Jun 11, 2024 Jun 11, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Other events
Apr 30, 2024 Apr 30, 2024
SC 13D/A Amended ownership over 5% (active) Apr 30, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 11, 2024
8-K Current report
Unregistered share sale
Apr 18, 2024 Apr 15, 2024
S-8 Employee stock plan registration Mar 26, 2024 —
10-K/A Amended annual report Mar 22, 2024 Dec 31, 2023
8-K Current report
Other events
Mar 22, 2024 Mar 22, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
8-K Current report
Other events
Feb 21, 2024 Feb 21, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
8-K Current report
Other events
Feb 2, 2024 Feb 2, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Oct 4, 2023 Oct 4, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Agreement ended
Jul 5, 2023 Jun 30, 2023
8-K Current report
Other events
Jun 28, 2023 Jun 28, 2023
8-K Current report
Material agreement
Jun 15, 2023 Jun 9, 2023
8-K Current report
Shareholder vote results
Jun 13, 2023 Jun 13, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Other events
May 10, 2023 May 10, 2023
EFFECT Filing May 2, 2023 —
CORRESP Letter to the SEC May 1, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Apr 27, 2023
UPLOAD Letter from the SEC Apr 12, 2023 —
S-3 Shelf registration Apr 7, 2023 —
S-8 Employee stock plan registration Mar 21, 2023 —
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 16, 2023 Mar 16, 2023
8-K Current report
Other events
Mar 15, 2023 Mar 15, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ETON (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Deer Park, IL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1710340

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.